Clinical study analysis on ulinastatin for treating systemic inflammatory response in patients with serious blood infection / 国际检验医学杂志
International Journal of Laboratory Medicine
; (12): 631-632, 2017.
Article
de Zh
| WPRIM
| ID: wpr-511406
Bibliothèque responsable:
WPRO
ABSTRACT
Objective To investigate the clinical effect of ulinastatin treating systemic inflammatory response in the patients with serious blood infection .Methods The patients with serious blood infection in our hospital were selected and divided into the control group and observation group .The control group was treated with the conventional treatment ,while on this basis the observation group was added with ulinastatin .The body temperature ,heart rate ,respiratory rate ,WBC ,Scr ,CRP ,PCT ,TNF-α,APACHE Ⅱscore and mortality rate were compared between the two groups .Results The body temperature ,heart rate ,respiratory rate and A-PACHE Ⅱ score in the observation group were lower than those in the control group ,moreover ,the levels of WBC ,CRP ,PCT , TNF-αand Scr ,and mortality rate in the observation group were lower than those in the control group ,the differences were statisti-cally significant (P<0 .05) .Conclusion Uinastatin has good effect for treating systemic inflammatory response in the patients with serious blood infection ,which can decrease the mortality and is worth clinical promotion .
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
International Journal of Laboratory Medicine
Année:
2017
Type:
Article